Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review
- PMID: 35292903
- DOI: 10.1007/s10689-022-00291-3
Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review
Abstract
Germline biallelic pathogenic variants (PVs) in NTHL1 have since 2015 been associated with the autosomal recessive tumor predisposition syndrome: NTHL1 tumor syndrome or NTHL1-associated polyposis. In this systematic review, we aim to systematically investigate the phenotypic and genotypic spectrum of the condition including occurrence of both benign and malignant tumors. The databases PubMed, EMBASE, and Scopus were searched. The search was conducted the 25th of august 2021. We included patients with germline PVs, both heterozygous and homo-/compound heterozygous carriers. Twenty-one papers were selected including 47 patients with biallelic PVs in NTHL1 in 32 families. Twenty-three out of 47 patients (49%) were diagnosed with colorectal cancer (CRC) (mean age: 55, range: 31-73) and 12 out of 22 female patients (55%) were diagnosed with breast cancer (mean age: 49, range: 36-63). Apart from three, all patients who underwent a colonoscopy, had colonic adenomas (93%), and three patients (6%) had duodenal adenomatosis. We also identified 158 heterozygous carriers of germline PVs in NTHL1. Twenty-six out of 68 (38%) heterozygous carriers, who underwent colonoscopy, had colonic polyps or adenomas. Twenty-nine heterozygous carriers (18%) were diagnosed with CRC and 59 (49%) with breast cancer. We observed a high frequency of early onset CRC and breast cancer in patients with NTHL1 tumor syndrome. Subsequently, colorectal, breast, and endometrial cancer screening programs are recommended for NTHL1 biallelic carriers. Trial registry PROSPERO: CRD42021275159.
Keywords: Breast cancer; Colorectal cancer; Extraintestinal neoplasms; Intestinal neoplasms; NTHL1 tumor syndrome; NTHL1-associated polyposis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.Sci Rep. 2019 Jun 21;9(1):9020. doi: 10.1038/s41598-019-45281-1. Sci Rep. 2019. PMID: 31227763 Free PMC article.
-
Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.Clin Genet. 2021 May;99(5):662-672. doi: 10.1111/cge.13925. Epub 2021 Feb 12. Clin Genet. 2021. PMID: 33454955
-
Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population.JCO Precis Oncol. 2021 Feb 26;5:PO.20.00443. doi: 10.1200/PO.20.00443. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34250384 Free PMC article.
-
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.Gastroenterology. 2017 Jan;152(1):75-77.e4. doi: 10.1053/j.gastro.2016.09.041. Epub 2016 Oct 3. Gastroenterology. 2017. PMID: 27713038 Free PMC article. Review.
-
NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?J Pathol. 2018 Feb;244(2):135-142. doi: 10.1002/path.5002. Epub 2017 Dec 14. J Pathol. 2018. PMID: 29105096 Review.
Cited by
-
NTHL1 is a recessive cancer susceptibility gene.Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.
-
TINF2 is a major susceptibility gene in Danish patients with multiple primary melanoma.HGG Adv. 2023 Jul 23;4(4):100225. doi: 10.1016/j.xhgg.2023.100225. eCollection 2023 Oct 12. HGG Adv. 2023. PMID: 37646013 Free PMC article.
-
Re-evaluating the genotypes of patients with adenomatous polyposis of unknown etiology: a nationwide study.Eur J Hum Genet. 2024 May;32(5):588-592. doi: 10.1038/s41431-024-01585-z. Epub 2024 Mar 12. Eur J Hum Genet. 2024. PMID: 38467732 Free PMC article.
-
Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.Genes (Basel). 2023 Apr 30;14(5):1025. doi: 10.3390/genes14051025. Genes (Basel). 2023. PMID: 37239385 Free PMC article. Review.
-
Hereditary polyposis syndromes remain a challenging disease entity: Old dilemmas and new insights.World J Gastrointest Surg. 2023 Jan 27;15(1):1-8. doi: 10.4240/wjgs.v15.i1.1. World J Gastrointest Surg. 2023. PMID: 36741069 Free PMC article. Review.
References
-
- Weren RDA et al (2015) A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 47(6):668–671. https://doi.org/10.1038/ng.3287 - DOI - PubMed
-
- Weren RDA, Ligtenberg MJ, Geurts van Kessel A, de Voer RM, Hoogerbrugge N, Kuiper RP (2018) NTHL1 and MUTYH polyposis syndromes: two sides of the same coin? J Pathol 244(2):135–142. https://doi.org/10.1002/path.5002 - DOI - PubMed
-
- Kuiper RP, Nielsen M, de Voer RM, Hoogerbrugge N (1993) NTHL1 tumor syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) Seattle (WA)
-
- Altaraihi M, Gerdes AM, Wadt K (2019) A new family with a homozygous nonsense variant in NTHL1 further delineated the clinical phenotype of NTHL1-associated polyposis. Hum Genome Var 6(1):1–3. https://doi.org/10.1038/s41439-019-0077-3 - DOI
-
- Belhadj S et al (2017) Delineating the phenotypic spectrum of the NTHL1-associated polyposis. Clin Gastroenterol Hepatol 15(3):461–462. https://doi.org/10.1016/J.CGH.2016.09.153 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials